CB vs NEPH · P/E 14, rev $59.40B vs P/E 48, rev $14.2M
Chubb Ltd (CB) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
CB currently screens at market cap $114.26B and trailing P/E 13.7. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the CB and NEPH stock pages for the full models.
Not investment advice.